Meet the key licensing contacts from big pharma including AbbVie, Amgen, AstraZeneca, Boehringer, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GE, GSK, Ipsen, J&J, Janssen R&D, Linde Healthcare, MSD, Novartis, Novo Nordisk, Shire, Pfizer, Takeda, Teijin, UCB as well as Vertex, Genus, EUSA, Nordic Pharma, Mercury and other senior BD&L execs
Meet 100 delegates from active VC and Corporate Venture firms including MedImmune Ventures, SR One, Shire Strategic Investment, AbbVie Biotech Ventures, Mitsui & Co., MPHVM, Norgine Investment Fund, Novartis Venture Fund, Takeda Ventures, Boehringer Ingelheim Ventures, Inventages, Amorepacific Ventures as well as Syncona, Index, Sofinnova and many international VCs
Meet a hand-picked crop of early-stage companies you haven’t seen elsewhere
Meet the senior execs who can complete the value chain for your business
![]()
For more information please click here